Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by Dwizellon Oct 24, 2019 10:03am

150 Views

Post# 30263800

RE:RE:RE:RE:RBC Report THTX 5 us dollars

SABBOBCAT wrote:
So if I remember correctly, his last price target was $6CAD, the new one is $6.50CAD... So essentially he is saying the entire Nash opportunity is worth 50 cents.

Considering the past, are you surprised ? As SPCE01 said, don't count on legacy anaysts to up their game.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?